Late in 2025, we covered the development of an AI system called Evo that was trained on massive numbers of bacterial genomes. So many that, when prompted with sequences from a cluster of related genes ...

Artificial intelligence promises to automate the white-collar work that made India a tech powerhouse. The country is racing to adapt before it’s too late.

In the Gemini app and on the website, Nano Banana 2 will be the image generator for the Fast, Thinking, and Pro settings.

India's most sensitive digital platforms from CoWIN to DigiYatra already run on AWS. The sovereign AI debate was settled by ...

India's homegrown AI startup Sarvam has quietly released its AI chat app Indus on app stores. The app is expected to work ...

Google has begun rolling out Lyria 3, its latest generative AI music model, inside Gemini. The beta feature is now live on the Gemini web app and will expand to mobile over the coming days. It allows ...

The new lineup includes 30-billion- and 105-billion-parameter models; a text-to-speech model; a speech-to-text model; and a vision model to parse documents.

A University of Michigan undergraduate student is suing the school, claiming she was falsely accused of using artificial intelligence in her coursework and denied disability accommodations during the ...

Artificial intelligence, meet the U.S. Supreme Court. It's an institution steeped in tradition and resistant to any quick changes in the way it does things. But like it or not, the justices are about ...

AI in daily life quietly powers devices we interact with every day, from smartphones and home appliances to navigation apps and wearables. Edge computing and tiny neural networks embedded in device ...

In a busy clinic, it's easy to imagine the scene: a clinician pastes a long consult note into a chatbot to get a clean summary, or asks it to draft an appeal letter for the fourth insurance denial of ...

Pfizer, Eli Lilly, Novartis, Bristol Myers Squibb and AstraZeneca are all ramping up the use of AI, but drug discovery is not the primary success story—yet. How did Pfizer slash billions in spending ...